CNE100001DP5
CNE100001DP5
DONGCHENG BIOCHEM
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 11.45B EUR | 10.35B EUR | 11.68B EUR |
Enterprise Value | 12.82B EUR | 10.96B EUR | 11.71B EUR |
Valuation Multiples | |||
Trailing P/E | 57.88x | 50.69x | 69.25x |
Forward P/E | 26.71x | -- | -- |
Price to Sales | 4.3x | 3.83x | 4.31x |
Price to Book | 2.6x | 2.35x | 2.72x |
EV/Revenue | 4.81x | 4.05x | 4.33x |
EV/EBITDA | 23.06x | 31.9x | 38.42x |
Price to FCF (P/FCF) | 193.21x | 386.45x | 146.56x |
EV/FCF | 216.25x | 409.21x | 147.05x |
FCF Yield | 0.52% | 0.26% | 0.68% |